Medeon Biodesign, Inc.(TW:6499)
NT$73.80-2.00 (-2.64%)
TW:6499
Medeon Biodesign, Inc. financials statements
NT$73.80
At close:-2.00 (-2.64%)
Medeon Biodesign, Inc. (6499) Ratios
Medeon Biodesign, Inc. Ratios
TW:6499's free cash flow for Q2 2026 was NT$-93.41M. For the 2026 fiscal year, TW:6499's free cash flow was decreased by NT$-61.00K and operating cash flow was NT$-93.35M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.21 | 6.11 | 10.05 | 8.25 | 14.91 |
| Quick Ratio | 8.06 | 5.95 | 10.00 | 8.20 | 14.91 |
| Cash Ratio | 3.24 | 2.38 | 5.58 | 2.44 | 4.59 |
| Solvency Ratio | -2.31 | -2.07 | -2.95 | -0.98 | 12.14 |
| Operating Cash Flow Ratio | -3.91 | -3.86 | -3.40 | -2.32 | -1.83 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 1.08B | NT$ 975.36M | NT$ 1.85B | NT$ 1.26B | NT$ 2.21B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.09 | 0.07 | 0.05 | 0.01 |
| Debt-to-Equity Ratio | 0.08 | 0.11 | 0.08 | 0.06 | 0.01 |
| Debt-to-Capital Ratio | 0.07 | 0.10 | 0.07 | 0.05 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.24 | 1.18 | 1.12 | 1.06 |
| Debt Service Coverage Ratio | -166.97 | -137.95 | -177.79 | -82.11 | -512.48 |
| Interest Coverage Ratio | -196.23 | -157.01 | -126.28 | -93.62 | -499.40 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.27 | 1.89 | 2.10 | 2.22 | 0.34 |
| Net Debt to EBITDA | 0.66 | 0.46 | 0.92 | 0.77 | 1.55 |
| Profitability Margins | |||||
| Gross Profit Margin | 14.03% | 28.49% | -33.22% | 62.62% | 41.52% |
| EBIT Margin | -172.26% | -291.35% | -630.58% | -145.45% | -743.77% |
| EBITDA Margin | -146.67% | -257.65% | -581.83% | -124.06% | -658.19% |
| Operating Profit Margin | -172.26% | -297.87% | -427.48% | -163.53% | -743.77% |
| Pretax Profit Margin | -171.59% | -293.24% | -633.96% | -147.20% | -745.26% |
| Net Profit Margin | -159.28% | -275.10% | -613.78% | -145.40% | 3013.75% |
| Continuous Operations Profit Margin | -171.51% | -297.30% | -653.98% | -182.55% | -878.85% |
| Net Income Per EBT | 92.83% | 93.81% | 96.82% | 98.78% | -404.39% |
| EBT Per EBIT | 99.61% | 98.45% | 148.30% | 90.01% | 100.20% |
| Return on Assets (ROA) | -37.54% | -42.90% | -43.85% | -10.74% | 47.62% |
| Return on Equity (ROE) | -45.27% | -52.99% | -51.92% | -12.06% | 50.32% |
| Return on Capital Employed (ROCE) | -44.63% | -52.48% | -33.22% | -12.70% | -12.20% |
| Return on Invested Capital (ROIC) | -43.50% | -50.81% | -32.61% | -12.58% | -12.16% |
| Return on Tangible Assets | -41.04% | -46.94% | -46.76% | -11.24% | 48.49% |
| Earnings Yield | -7.66% | -22.04% | -28.06% | -8.52% | 31.57% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.03 | 6.80 | 4.70 | 5.06 | 4.72 |
| Payables Turnover | 47.74 | 17.45 | 48.77 | 28.31 | 896.13 |
| Inventory Turnover | 14.52 | 6.14 | 24.28 | 11.09 | 0.00 |
| Fixed Asset Turnover | 1.56 | 0.81 | 0.57 | 0.88 | 1.55 |
| Asset Turnover | 0.24 | 0.16 | 0.07 | 0.07 | 0.02 |
| Working Capital Turnover Ratio | 0.37 | 0.19 | 0.11 | 0.16 | 0.03 |
| Cash Conversion Cycle | 57.90 | 92.21 | 85.24 | 92.23 | 76.96 |
| Days of Sales Outstanding | 40.41 | 53.68 | 77.69 | 72.20 | 77.36 |
| Days of Inventory Outstanding | 25.14 | 59.44 | 15.03 | 32.93 | 0.00 |
| Days of Payables Outstanding | 7.65 | 20.92 | 7.48 | 12.89 | 0.41 |
| Operating Cycle | 65.55 | 113.12 | 92.72 | 105.12 | 77.36 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.82 | -9.03 | -8.21 | -5.01 | -3.20 |
| Free Cash Flow Per Share | -7.00 | -9.84 | -8.81 | -6.54 | -3.30 |
| Dividend Paid and CapEx Coverage Ratio | -38.19 | -11.14 | -7.62 | -2.16 | -32.55 |
| Capital Expenditure Coverage Ratio | -38.19 | -11.14 | -13.66 | -3.28 | -32.55 |
| Operating Cash Flow Coverage Ratio | -5.56 | -4.94 | -4.04 | -2.32 | -9.70 |
| Operating Cash Flow to Sales Ratio | -1.50 | -2.84 | -3.85 | -1.55 | -4.25 |
| Free Cash Flow Yield | -7.40% | -24.82% | -18.88% | -11.83% | -4.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -13.05 | -4.54 | -3.56 | -11.75 | 3.17 |
| Price-to-Sales (P/S) Ratio | 20.79 | 12.48 | 21.87 | 17.07 | 95.47 |
| Price-to-Book (P/B) Ratio | 5.91 | 2.40 | 1.85 | 1.42 | 1.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.51 | -4.03 | -5.30 | -8.46 | -21.77 |
| Price-to-Operating Cash Flow Ratio | -13.86 | -4.39 | -5.69 | -11.04 | -22.44 |
| Price-to-Earnings Growth (PEG) Ratio | 0.76 | 0.14 | -0.02 | 0.10 | -0.00 |
| Enterprise Value Multiple | -13.51 | -4.39 | -2.84 | -12.99 | -12.95 |
| Enterprise Value | 8.31B | 3.31B | 3.24B | 4.81B | 5.88B |
| EV to EBITDA | -13.51 | -4.39 | -2.84 | -12.99 | -12.95 |
| EV to Sales | 19.82 | 11.31 | 16.52 | 16.11 | 85.24 |
| EV to Free Cash Flow | -12.88 | -3.65 | -4.00 | -7.98 | -19.44 |
| EV to Operating Cash Flow | -13.21 | -3.98 | -4.29 | -10.42 | -20.04 |
| Tangible Book Value Per Share | 15.01 | 14.91 | 23.91 | 37.86 | 44.79 |
| Shareholders’ Equity Per Share | 15.99 | 16.49 | 25.21 | 39.10 | 45.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.01 | -0.03 | -0.13 | -0.14 |
| Revenue Per Share | 4.55 | 3.18 | 2.13 | 3.24 | 0.75 |
| Net Income Per Share | -7.24 | -8.74 | -13.09 | -4.71 | 22.65 |
| Tax Burden | 0.93 | 0.94 | 0.97 | 0.99 | -4.04 |
| Interest Burden | 1.00 | 1.01 | 1.01 | 1.01 | 1.00 |
| Research & Development to Revenue | 1.39 | 2.57 | 3.38 | 1.72 | 6.03 |
| SG&A to Revenue | 0.29 | 0.70 | 0.95 | 0.51 | 1.57 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.08 | 0.01 | 0.09 |
| Income Quality | 0.87 | 0.97 | 0.63 | 1.05 | -0.14 |
Currency in TWD
